A molecular history of the amyloidoses.
The molecular investigation of the amyloidoses began in the mid-19th century with the observation of areas in human tissues obtained at autopsy that were homogeneous and eosinophilic with conventional stains but became blue when exposed to mixtures of iodine and sulfuric acid. The foci corresponded to regions formerly identified as "waxy" or lardaceous. Subsequent identification of the characteristic staining of the same tissues with metachromatic dyes such as crystal violet or with the cotton dye Congo red (particularly under polarized light) and thioflavins allowed the pathological classification of those tissues as belonging to a set of disorders known as the amyloidoses. Not unexpectedly, progress has reflected evolving technology and parallel advances in all fields of biological science. Investigation using contemporary methods has expanded our notions of amyloid proteins from being simply agents or manifestations of systemic, largely extracellular diseases to include "protein-only infection," the concept that "normal" functional amyloids might exist in eukaryotes and prokaryotes and that aggregatability may be an intrinsic structural price to be paid for some functional protein domains. We now distinguish between the amyloidoses, that is, diseases caused by the deposition of amyloid fibrils and amyloid proteins (i.e., purified or recombinant proteins that form amyloid fibrils in vitro), which may or may not be associated with disease in vivo.
Department of Molecular and Experimental Medicine (MEM230), The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. jbux@scripps.ed
Joel N
JN
Buxbaum
Reinhold P
RP
Linke
D000686:Amyloidosis / Q000235:genetics* / Q000276:immunology / Q000378:metabolism; D001703:Biophysics; D006801:Humans; D007147:Immunoglobulin Light Chains / Q000378:metabolism; D013194:Staining and Labeling
D007147:Immunoglobulin Light Chains